Labiotech.eu

News and Trends 30 Jun 2021

GSK Raises Eyebrows in Checkpoint Inhibitor Megadeal with iTeos

Analysts are abuzz over GSK’s co-development deal with immuno-oncology specialist iTeos Therapeutics earlier this month, wondering if it overpaid for the Belgian company’s next-generation checkpoint inhibitor. GSK’s oncology deal with iTeos earlier this month centered on an antibody drug that blocks an immune checkpoint called TIGIT. The candidate is currently in phase I testing for […]

June 30, 2021 - 5 minutesmins - By Victor Kotsev

Best in Biotech 30 Jun 2021

Scotland’s Top 10 Biotech Companies to Watch Out For

Scotland has a thriving life sciences ecosystem with strengths in oncology, genetic engineering, and industrial biotech. Let’s pick up the bagpipes as we tour the top 10 biotech companies in Scotland. Scotland is the UK’s second-most populous country, boasting picturesque scenery, a rich history, and a strong focus on sustainability. There is a diverse range […]

June 30, 2021 - 11 minutesmins - By Jonathan Smith

In Depth 28 Jun 2021

Transforming Food Waste into Bioenergy

Food waste is one of the many environmental problems caused by modern agriculture. Biotechnology innovations may help us tackle it by turning waste into energy. For decades now, bioenergy has been posited as a renewable and clean source of energy. Biomass, particularly from forestry, is the largest source of renewable energy in the UK. However, […]

June 28, 2021 - 6 minutesmins - By Sachin Rawat

In Depth 23 Jun 2021

How Blockchain Companies Are Helping Us Protect Our Genomic Data

Using genomic data and the blockchain network, it is now possible to send anonymous genetic information around the world in the blink of an eye. Meet the companies that want to help us protect and control our own genetic data. As the cost of sequencing an individual genome falls and more people have access to […]

June 23, 2021 - 7 minutesmins - By Helen Albert

epigenetics oncology car t mnemo therapeutics

News and Trends 22 Jun 2021

Huge Series A in France Strengthens European Epigenetic Oncology

Mnemo Therapeutics has raised €75M in the largest-ever French Series A round, which it will use to develop CAR-T cell immunotherapies for cancer using epigenetic targets. Mnemo Therapeutics’ mammoth financing, led by Casdin Capital, returning investor Sofinnova Partners, and an undisclosed investor, will allow the startup to accelerate the development of its epigenetic targeting and […]

June 22, 2021 - 4 minutesmins - By Laura Cowen

Inside Labiotech 21 Jun 2021

What’s New for Labiotech.eu’s 6th Birthday?

It’s Labiotech’s 6th anniversary! We’re super proud of what we accomplished over the past 6 years and we’d like to thank everyone who contributed to this adventure since our humble beginnings in 2015. Thank you to our team members, freelancers, contributors, and partners—we couldn’t have made it this far without your commitment and support! We’re […]

June 21, 2021 - 3 minutesmins - By Joachim Eeckhout

Opinion 21 Jun 2021

A Window to the Past: Is the Biotech Investment Boom Going to Last?

The biotech industry has been going through a period of fast growth in recent years. To uncover whether the current biotech investment boom will last, let’s look at what history can teach us. A window is something that opens and shuts. So the clear implication of everyone talking about a ‘public market window’ in the […]

June 21, 2021 - 7 minutesmins - By External Contributor

News and Trends 17 Jun 2021

FDA Approval of Biogen’s Drug Boosts European Alzheimer’s Space

The FDA shocked many life sciences observers by greenlighting Biogen’s treatment candidate for Alzheimer’s last week. Yet, for much of the Alzheimer’s disease community on both sides of the Atlantic, the decision also brings cautious hope. Controversy recently erupted when the FDA conditionally granted accelerated approval to Biogen’s aducanumab, making it the first approved treatment […]

June 17, 2021 - 6 minutesmins - By Victor Kotsev

Expert Advice 16 Jun 2021

What Makes a Biotech Executive Stand Out?

Talented executives are always in demand in the biotech industry. Leaders who stand out in the field demonstrate flexibility to deal with change and failure, as well as a track record of hitting milestones. Successful biotechs typically progress along similar paths, moving from small scientist-driven enterprises eager to test their ideas, to established companies with […]

June 16, 2021 - 6 minutesmins - By Mark Zipkin

covid 19 vaccine patent waiver intellectual property ip

News and Trends 15 Jun 2021

Patent Waiver on Covid-19 Vaccines Splits Opinions in Biotech Industry

Attempts to increase global Covid-19 vaccine coverage with a temporary patent waiver have been met with hostility from many big pharma and biotech companies, but some smaller players welcome the idea. With the Covid-19 pandemic still rampaging through many countries and new viral variants popping up with alarming regularity, scuffles over who holds intellectual property […]

June 15, 2021 - 5 minutesmins - By Anita Chakraverty

In Depth 14 Jun 2021

Biomimicry in Biotech: Taking Inspiration from Nature

Scouring the natural world can be an effective way of finding design inspiration for new scientific innovation. Several biotech companies are using biomimicry to develop weird and wonderful bio-inspired products. If you’re looking to design a new tool to overcome a scientific challenge, chances are that evolution has beaten you to it. It’s not […]

June 14, 2021 - 7 minutesmins - By Farhan Mitha

dna sequencing covid 19 vaccine funding european biotech investment

News and Trends 10 Jun 2021

The Top European Biotech Investment Rounds in May

Last month saw huge biotech investment rounds dedicated to Covid-19 vaccines in Europe, including IPOs by Valneva and Vaccitech. However, a €227M (£195M) private round by the DNA sequencing giant Oxford Nanopore Technologies made the biggest splash. Last month was a difficult one for a number of public biotech companies. Biotech stock indices proved volatile […]

June 10, 2021 - 4 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

GSK Raises Eyebrows in Checkpoint Inhibitor Megadeal with iTeos

Scotland’s Top 10 Biotech Companies to Watch Out For

Transforming Food Waste into Bioenergy

How Blockchain Companies Are Helping Us Protect Our Genomic Data

Huge Series A in France Strengthens European Epigenetic Oncology

What’s New for Labiotech.eu’s 6th Birthday?

A Window to the Past: Is the Biotech Investment Boom Going to Last?

FDA Approval of Biogen’s Drug Boosts European Alzheimer’s Space

What Makes a Biotech Executive Stand Out?

Patent Waiver on Covid-19 Vaccines Splits Opinions in Biotech Industry

Biomimicry in Biotech: Taking Inspiration from Nature

The Top European Biotech Investment Rounds in May

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!